Healthcare Services

Theranostics Market Expected To Witness Revenue Growth Toward $205.53 Billion By 2030

June 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Theranostics Market By 2030 Based On Its 2026 Value?

The theranostics market has experienced rapid expansion in recent years. It is anticipated to grow from $122.98 billion in 2025 to $136.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.6%. Historically, this growth can be attributed to advancements in molecular diagnostics, the increased prevalence of chronic diseases, the proliferation of oncology-focused research programs, the availability of targeted therapeutics, and the expansion of diagnostic laboratory infrastructure.

The theranostics market is anticipated to experience substantial growth in the coming years. It is projected to achieve a size of $205.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period is attributable to increasing investments in precision medicine, the rising adoption of AI-driven diagnostic tools, the broadening of theranostic applications in oncology, the deeper integration of genomics into clinical practice, and a higher demand for personalized treatment outcomes. Significant trends foreseen for this period include the intensifying integration of diagnostics with targeted therapies, the growing uptake of personalized medicine platforms, the expanding utilization of molecular imaging techniques, the advancement in companion diagnostic development, and an enhanced focus on patient-specific treatment pathways.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp

What Core Drivers Are Transforming The Theranostics Market?

The increasing incidence of cancer is anticipated to drive expansion in the theranostics market moving ahead. Cancer, characterized by uncontrolled cell multiplication, affects numerous organs and is a major cause of illness and death globally. Theranostics, which combines therapeutic and diagnostic approaches, holds considerable promise for managing cancer and chronic diseases. This method facilitates individualized and precise treatments through the integration of diagnostic and therapeutic functionalities, opening avenues for innovation within the healthcare sector. Consequently, the growing population of cancer patients will fuel the expansion of the theranostics market. For example, in August 2024, Macmillan Cancer Support, a UK-based organization, reported that over 3 million individuals in the UK are living with cancer in 2024, with this number forecasted to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Thus, the escalating prevalence of cancer is a key driver for the theranostics market.

How Are Different Segment Groups Identified Within The Theranostics Market?

The theranostics market covered in this report is segmented –

1) By Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases

2) By Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy

2) By Cardiovascular Diseases: Coronary Artery Disease, Heart Failure, Atrial Fibrillation, Hypertension

3) By Immunological Disorders: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Psoriasis

4) By Oncology Diseases: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer

5) By Other Diseases: Infectious Diseases, Metabolic Disorders, Genetic Disorders

Which Trends Are Affecting The Theranostics Market Framework?

Leading firms within the testicular cancer market are concentrating on creating novel therapies, specifically cell-engaging bispecific antibodies, targeting CLDN6-positive gynecologic and testicular cancers. These antibodies function by attaching to two separate targets, thereby enabling immune cells to become active and subsequently eliminate cancerous or diseased cells. As an example, in May 2024, Context Therapeutics Inc., a US-based biopharmaceutical entity, disclosed that the U.S. Food and Drug Administration (FDA) had approved its Investigational New Drug (IND) application for CTIM-76, which is a CLDN6 x CD3 T cell-engaging bispecific antibody. This approval permits the company to commence a Phase 1 clinical trial to assess CTIM-76 in individuals diagnosed with CLDN6-positive gynecologic and testicular cancers. The study is designed to involve dose escalation and expansion phases, aiming to determine the drug’s safety, effectiveness, and how it moves through the body.

Which Organizations Are Operating Within The Theranostics Market?

Major companies operating in the theranostics market are Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Thermo Fisher Scientific Inc, Astellas Pharma, Radiopharm Theranostics Ltd, Alpha-Theranostics, Cardio-Theranostics LLC, Curium, Theradiag, Cell Theranostics, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc, Qiagen NV, Foundation Medicine Inc., Leica Biosystems Nussloch GmBH, Pfizer Inc., Siemens Healthineers, Advanced Accelerator Applications, AstraZeneca plc, Bayer AG, Bio-Rad Laboratories, Bristol-Myers Squibb Company, Danaher Corporation, Illumina Inc., Merck KGaA, Roche Diagnostics Corporation, PerkinElmer Inc.

Access The Complete Theranostics Market Report:

https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report

Which Region Leads The Theranostics Market By Size?

North America was the largest region in the global theranostics market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the theranostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Theranostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=10823&type=smp

Browse Through More Reports Similar to the Global Theranostics Market 2026, By The Business Research Company

Radiopharmaceutical Theranostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-theranostics-global-market-report

Music Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/music-therapy-global-market-report

Antidotes Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidotes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795